Withdrawal of Albuterol Inhalers Containing Chlorofluorocarbon Propellants  

Oleh:

Hendeles, Leslie ; Colice, Gene L ; Meyer, Robert J.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 356 no. 13 (Mar. 2007), page 1344.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2007.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Inhaled short-acting 2-agonists are indicated for short-term relief of symptoms related to bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD). Albuterol (called salbutamol outside the United States) is delivered by a metered-dose inhaler, the most widely used drug and delivery method in this class of agents worldwide. In the United States, about 52 million prescriptions for albuterol are filled annually, mostly as generic products containing chlorofluorocarbon (CFC) propellants,1 making it the seventh most commonly prescribed medication in the country. A similar number of albuterol metered-dose inhalers are prescribed in Europe, most containing a hydrofluoroalkane (HFA) propellant.2 Dry-powder . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali